Margrét Helga Ögmundsdóttir

Our mission: We believe that strong focus on RNA quality is essential to realize the full potential of RNA-based medicine.
Enzyme engineering: We have developed a proprietary AI-driven screening platform to design novel, patent-protected RNA polymerases for a wide range of applications.
Purification technology: Our proprietary purification platform enables the production of highly pure RNA polymerases, resulting in consistently high-quality RNA.
mRNA platform: We have established a platform for producing mRNA that achieves higher protein expression in animal models compared with industry standards.

Ternaria Biosciences